Drug Designed to Fight MS Could Target Viral Infections

August 14, 2008

Reuters is reporting today that a new drug, FTY720, also called fingolimod, that Novartis AG is testing in individuals with multiple sclerosis could also tackle some viral infections, including perhaps including meningitis and perhaps even the AIDS virus. For the complete article,

Reuters is reporting today that a new drug, FTY720, also called fingolimod, that Novartis AG is testing in individuals with multiple sclerosis could also tackle some viral infections, including perhaps including meningitis and perhaps even the AIDS virus. For the complete article, CLICK HERE.

Source: Reuters